Structures by: Richardson D. R.
Total: 28
C19H15BrN4S
C19H15BrN4S
Organic & biomolecular chemistry (2013) 11, 37 6414-6425
a=9.5013(5)Å b=10.0576(5)Å c=10.2659(5)Å
α=63.494(2)° β=85.295(3)° γ=77.804(3)°
C20H18N4S
C20H18N4S
Organic & biomolecular chemistry (2013) 11, 37 6414-6425
a=9.5261(12)Å b=9.7850(11)Å c=11.566(2)Å
α=101.101(6)° β=106.020(6)° γ=115.357(4)°
C12H14N4O3
C12H14N4O3
Dalton transactions (Cambridge, England : 2003) (2007) 30 3232-3244
a=6.4200(10)Å b=8.0010(10)Å c=12.943(2)Å
α=87.76(2)° β=76.47(2)° γ=80.730(10)°
C12H10N4O1
C12H10N4O1
Dalton transactions (Cambridge, England : 2003) (2007) 30 3232-3244
a=8.4690(10)Å b=13.836(2)Å c=9.806(2)Å
α=90° β=105.640(10)° γ=90°
C13H10Br1N3O,2(H2O)
C13H10Br1N3O,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 30 3232-3244
a=26.311(3)Å b=26.311(3)Å c=11.2700(10)Å
α=90° β=90° γ=120°
C13H11N3O2
C13H11N3O2
Dalton transactions (Cambridge, England : 2003) (2007) 30 3232-3244
a=4.6180(10)Å b=22.759(3)Å c=10.663(3)Å
α=90° β=96.98(2)° γ=90°
C13H11Br1N3O,ClO4,2(H2O))
C13H11Br1N3O,ClO4,2(H2O))
Dalton transactions (Cambridge, England : 2003) (2007) 30 3232-3244
a=6.839(5)Å b=16.527(5)Å c=15.507(5)Å
α=90° β=90.079(5)° γ=90°
C13H11Br1N3O,ClO4,H2O
C13H11Br1N3O,ClO4,H2O
Dalton transactions (Cambridge, England : 2003) (2007) 30 3232-3244
a=10.4340(10)Å b=10.7200(6)Å c=14.691(2)Å
α=90° β=90° γ=90°
C26H48Br4Fe2N12O2,0.5(C4H8O2)
C26H48Br4Fe2N12O2,0.5(C4H8O2)
Dalton transactions (Cambridge, England : 2003) (2007) 30 3232-3244
a=13.833(3)Å b=14.191(3)Å c=16.863(2)Å
α=69.80(1)° β=89.23(1)° γ=64.05(2)°
C18H23N3O3
C18H23N3O3
Dalton transactions (Cambridge, England : 2003) (2018) 47, 21 7190-7205
a=21.0616(14)Å b=6.5769(6)Å c=25.0650(18)Å
α=90° β=104.603(7)° γ=90°
C36H44Cl2Cu2N6O4,H2O
C36H44Cl2Cu2N6O4,H2O
Dalton transactions (Cambridge, England : 2003) (2018) 47, 21 7190-7205
a=7.3255(5)Å b=9.7556(5)Å c=14.3516(9)Å
α=101.145(5)° β=90.371(5)° γ=108.493(6)°
C19H26Cl2Cu1N4O3,0.75CH4O
C19H26Cl2Cu1N4O3,0.75CH4O
Dalton transactions (Cambridge, England : 2003) (2018) 47, 21 7190-7205
a=8.6653(5)Å b=12.8542(6)Å c=22.1094(10)Å
α=99.037(5)° β=93.119(5)° γ=105.051(5)°
C36H44FeN6O4,ClO4,0.5(C2H6O)
C36H44FeN6O4,ClO4,0.5(C2H6O)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 21 7190-7205
a=11.0978(9)Å b=12.7887(10)Å c=14.2619(12)Å
α=77.005(7)° β=81.372(7)° γ=87.444(7)°
C9H11N3S2
C9H11N3S2
Dalton transactions (Cambridge, England : 2003) (2012) 41, 21 6536-6548
a=5.8633(5)Å b=8.1483(10)Å c=11.7569(15)Å
α=81.909(10)° β=79.334(9)° γ=84.497(8)°
C16H16FeN6S4,ClO4
C16H16FeN6S4,ClO4
Dalton transactions (Cambridge, England : 2003) (2012) 41, 21 6536-6548
a=33.4374(17)Å b=8.8580(4)Å c=14.8651(10)Å
α=90° β=90.851(5)° γ=90°
C16H15Fe1N6O1S4,C3H6O
C16H15Fe1N6O1S4,C3H6O
Dalton transactions (Cambridge, England : 2003) (2012) 41, 21 6536-6548
a=36.376(5)Å b=36.376(5)Å c=9.3420(7)Å
α=90° β=90° γ=120°
2-pyridylcarboxaldehyde isonicotinoyl hydrazone
C12H10N4O
Acta Crystallographica Section C (1999) 55, 12 2102-2105
a=43.749(10)Å b=20.984(2)Å c=4.5980(10)Å
α=90.00° β=90.00° γ=90.00°
2-pyridinecarboxaldehyde benzoyl hydrazone hydrate
C13H11N3O1,H2O1
Acta Crystallographica Section C (1999) 55, 12 2102-2105
a=7.1468(6)Å b=11.994(7)Å c=29.493(5)Å
α=90.00° β=90.00° γ=90.00°
2-furfuryl isonicotinoyl hydrazone
C11H9N3O2
Acta Crystallographica Section C (1999) 55, 12 2102-2105
a=14.188(3)Å b=5.2850(3)Å c=26.954(6)Å
α=90.00° β=93.550(10)° γ=90.00°
C13H13N3OS
C13H13N3OS
Acta Crystallographica Section C (2000) 56, 3 341-342
a=8.0560(10)Å b=6.7586(6)Å c=11.694(3)Å
α=90.00° β=102.930(10)° γ=90.00°
1-[(4-ethylthiosemicarbazono)methyl]-2-naphthol
C14H15N3OS
Acta Crystallographica Section C (2003) 59, 11 o629-o633
a=26.608(8)Å b=7.0551(6)Å c=18.918(5)Å
α=90° β=129.710(10)° γ=90°
1-[(4-phenylthiosemicarbazono)methyl]-2-naphthol
C18H15N3OS
Acta Crystallographica Section C (2003) 59, 11 o629-o633
a=19.243(4)Å b=6.7948(6)Å c=24.471(6)Å
α=90° β=95.480(10)° γ=90°
1-[(4-methylthiosemicarbazono)methyl]-2-naphthol
C13H13N3OS
Acta Crystallographica Section C (2003) 59, 11 o629-o633
a=9.2930(10)Å b=5.1612(3)Å c=12.5630(10)Å
α=90° β=91.31(2)° γ=90°
1-[(4,4-dimethylthiosemicarbazono)methyl]-2-naphthol dimethyl sulfoxide solvate
C14H15N3OS,C2H6OS
Acta Crystallographica Section C (2003) 59, 11 o629-o633
a=12.012(2)Å b=7.8776(9)Å c=18.631(3)Å
α=90° β=95.780(10)° γ=90°
(hapta^6^-p-Cymene)[6-(4-methylpiperazin-1-ium)-kappaN-(pyridin-2-yl-methylene)-11H- indolo[3,2-c]quinolin-2-kappaN-amine]chloridoruthenium(II) dichloride ethanol water solvate
C36H39ClN6Ru,C2H6O,2(Cl),2(H2O)
Inorganic chemistry (2014) 53, 13 6934-6943
a=19.2712(14)Å b=7.8687(5)Å c=25.5459(19)Å
α=90.00° β=91.724(4)° γ=90.00°
(hapta^6^-p-Cymene)[6-(4-methylpiperazin-1-yl)-kappaN-(pyridin-2-yl-methylene)-11H- indolo[3,2-c]quinolin-4-kappaN-amine]chloridoruthenium(II) chloride
C36H38ClN6Ru,0.5(C2H6O),Cl,(H2O)
Inorganic chemistry (2014) 53, 13 6934-6943
a=10.0291(4)Å b=9.4460(4)Å c=19.2958(7)Å
α=90.00° β=93.479(2)° γ=90.00°
(hapta^6^-p-Cymene)[6-(4-methylpiperazin-1-ium)-kappaN-(pyridin-2-yl-methylene)-11H- indolo[3,2-c]quinolin-4-kappaN-amine]chloridoruthenium(II) dichloride isopropanal water solvate
C36H39ClN6Ru,1.5(C3H8O),2(Cl),0.5(H2O)
Inorganic chemistry (2014) 53, 13 6934-6943
a=15.2896(5)Å b=19.5424(6)Å c=15.3917(5)Å
α=90.00° β=113.677(2)° γ=90.00°
C26H22FeN8S4,C13H11N4S,2(ClO4)
C26H22FeN8S4,C13H11N4S,2(ClO4)
Dalton transactions (Cambridge, England : 2003) (2012) 41, 21 6536-6548
a=7.9883(3)Å b=14.5465(7)Å c=20.3055(9)Å
α=89.484(4)° β=82.777(4)° γ=84.060(4)°